cp 115953 has been researched along with moxifloxacin in 1 studies
| Studies (cp 115953) | Trials (cp 115953) | Recent Studies (post-2010) (cp 115953) | Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 3,157 | 552 | 1,690 |
| Protein | Taxonomy | cp 115953 (IC50) | moxifloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Staphylococcus aureus | 5.1033 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 1.4 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 1.4 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.8 | |
| DNA gyrase subunit A | Staphylococcus aureus | 7.25 | |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 8.525 | |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 8.66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azéma, J; Dewelle, J; Guidetti, B; Kiss, R; Korolyov, A; Le Calve, B; Malet-Martino, M; Martino, R; Mijatovic, T; Vaysse, J | 1 |
1 other study(ies) available for cp 115953 and moxifloxacin
| Article | Year |
|---|---|
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Humans; Maximum Tolerated Dose; Mice; Neoplasms; Piperazine; Piperazines | 2009 |